HDS CDTR Diabetes and Obesity Prevention Core
HDS CDTR 糖尿病和肥胖预防核心
基本信息
- 批准号:10016266
- 负责人:
- 金额:$ 6.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdultAdvanced DevelopmentAffectAgeAmericanAreaBirth WeightCaliforniaCaringCenters for Disease Control and Prevention (U.S.)CertificationChildChildhoodChronic DiseaseClinicalClinical TrialsCollaborationsConsultationsDiabetes MellitusDiabetes preventionDiagnosisEffectivenessExposure toFinancial SupportFosteringFoundationsFundingFutureGenerationsGestational AgeGestational DiabetesHealthHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsImpaired fasting glycaemiaImprove AccessInstitutesIntegrated Delivery SystemsInterventionJointsKnowledgeLifeLife ExperienceLife StyleMetabolic syndromeMethodsMinority GroupsMissionModalityMorbidity - disease rateMorehouse School of MedicineNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusObesityObesity EpidemicOverweightPaperPatientsPhysiciansPopulationPostpartum PeriodPostpartum WomenPregnancyPregnant WomenPrevalencePreventionPrevention ResearchPrevention programProviderPublicationsQuality of CareRecording of previous eventsRecurrenceReportingResearchResearch PersonnelResearch PriorityResearch Project GrantsResearch SupportResourcesRisk FactorsSan FranciscoSiteStructureSupport SystemSystemTimeTrainingTranslatingTranslational ResearchUnderrepresented MinorityUnderserved PopulationUnited StatesUniversitiesVulnerable PopulationsWeight GainWomanadult obesitybasecardiometabolismcollaborative environmentcostdiabetes prevention programdiabetes riskeducation researcheffective interventionethnic minority populationevidence basegestational weight gainhealth care deliveryhealth care disparityhealth information technologyhealth traininghigh riskimpaired glucose toleranceinterestlow socioeconomic statusmaternal hyperglycemiamaternal obesityminority investigatormortalitymultidisciplinarynovelobesity developmentobesity in childrenobesity preventionobesity riskoffspringpatient outreachpopulation basedpostpartum weightprenatal exposurepreventprogramsracial and ethnicranpirnasereproductiveresponsesafety netsymposiumsystems researchtailored messaginguptake
项目摘要
Diabetes mellitus is a significant health burden in the United States, affecting more than 20,000,000
people and costing more than $100 billion annually. The prevalence of Type 2 diabetes (T2DM) is growing
rapidly; the CDC estimates that up to 1/3 of Americans will have diabetes by the year 2050. The burden of
T2DM is particularly great among ethnic minority populations and those of lower socioeconomic status. The
evidence base for the prevention and care of T2DM is one of the most well-established of any chronic illness:
clinical trials have shown the efficacy of cardiometabolic therapies in preventing mortality and morbidity in
diabetes, and programs such as the Diabetes Prevention Program (DPP) have demonstrated that diabetes can
be prevented in high-risk patients. However, the overall quality of care for diabetes remains sub-optimal,
significant disparities in diabetes care and prevention persist, and there are very few effective populationbased
efforts to systematically reduce prevent diabetes and reduce diabetes risk. Programs that can effectively
translate high-quality, evidence-based diabetes prevention and treatment into widespread practice are
desperately needed.
In response to this need, diabetes researchers at the Kaiser Permanente Northern California Division of
Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the
University of California San Francisco (UCSF) created the Health Delivery Systems Center for Diabetes
Translational Research (HDS-CDTR) in 2011 (P30 DK092924). This CDTR fosters and supports translational
research in diabetes within health care delivery systems affiliated with the Health Care Systems Research
Network (formerly known as the HMO Research Network) and with UCSF. The HDS- CDTR brings together a
multi-disciplinary network of well-established investigators with a strong history of receiving federal and
foundation funding in diabetes translational research. The HDS-CDTR is structured around three Translational
Research Cores in the areas of health care disparities; diabetes and obesity prevention; and health information
technology. HDS-CDTR investigators have strong relationships with delivery systems, ranging from large
integrated delivery systems to networks of safety net providers that serve as key partners for translating
effective interventions into real-world clinical settings. Our CDTR will continue to be a strong resource to underresourced
delivery systems across the U.S. through its Resource Core, which will continue and expand our
support of these systems in their efforts to provide high quality diabetes prevention and care. In addition, the
HDS-CDTR is expanding its mission to address disparities through the creation of a new Core for Underserved
Populations that will develop a strong partnership with junior and senior Underrepresented Minority (URM)
investigators at the Morehouse School of Medicine.
糖尿病是美国的重大健康负担,影响超过20,000,000
人们每年耗资超过1000亿美元。 2型糖尿病(T2DM)的患病率正在增长
迅速疾病预防控制中心估计,到2050年,多达1/3的美国人将患有糖尿病。
T2DM在少数民族和社会经济地位较低的人群中尤其重要。这
预防和护理T2DM的证据基础是任何慢性疾病中最有公认的:
临床试验表明,心脏代谢疗法在预防死亡率和发病率方面的功效
糖尿病和糖尿病预防计划(DPP)等计划表明糖尿病可以
高危患者可以预防。但是,糖尿病的总体护理质量仍然是最佳的,
糖尿病护理和预防的显着差异持续存在,有效的人群很少
努力系统地减少糖尿病并降低糖尿病风险。可以有效的程序
将高质量,基于证据的糖尿病预防和治疗转化为广泛的实践是
迫切需要。
为了应对这一需求,Kaiser Permanente North California司的糖尿病研究人员
研究,HealthPartners教育与研究所,哈佛大学朝圣者卫生保健研究所和
加利福尼亚大学旧金山大学(UCSF)创建了糖尿病的健康输送系统中心
2011年转化研究(HDS-CDTR)(P30 DK092924)。此CDTR促进并支持翻译
医疗保健系统研究隶属于医疗保健提供系统中糖尿病的研究
网络(以前称为HMO研究网络)和UCSF。 HDS- CDTR汇集了
良好的调查员的多学科网络,该研究人员有悠久的历史,即接受联邦和
糖尿病转化研究中的基金会资金。 HDS-CDTR的结构大约是三个翻译
医疗保健差异领域的研究核心;糖尿病和肥胖预防;和健康信息
技术。 HDS-CDTR调查人员与交付系统有牢固的关系,从大型
将交付系统集成到安全网络提供商网络,这些提供商是翻译的关键合作伙伴
有效干预现实世界临床环境。我们的CDTR将继续成为资源不足的强大资源
通过其资源核心,美国各地的交付系统将继续并扩展我们
支持这些系统为提供高质量糖尿病预防和护理的努力。另外,
HDS-CDTR正在扩大通过创建新的核心来解决差异的使命
人口将与初级和高级代表性不足的少数民族(URM)建立牢固的伙伴关系
莫尔豪斯医学院的调查人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASSIAMIRA FERRARA其他文献
ASSIAMIRA FERRARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASSIAMIRA FERRARA', 18)}}的其他基金
Appropriate Gestational Weight Gain in Overweight/Obese Women
超重/肥胖女性妊娠期体重适当增加
- 批准号:
8506337 - 财政年份:2013
- 资助金额:
$ 6.84万 - 项目类别:
Appropriate Gestational Weight Gain in Overweight/Obese Women
超重/肥胖女性妊娠期体重适当增加
- 批准号:
8811996 - 财政年份:2013
- 资助金额:
$ 6.84万 - 项目类别:
Appropriate Gestational Weight Gain in Overweight/Obese Women
超重/肥胖女性妊娠期体重适当增加
- 批准号:
9222784 - 财政年份:2013
- 资助金额:
$ 6.84万 - 项目类别:
Appropriate Gestational Weight Gain in Overweight/Obese Women
超重/肥胖女性妊娠期体重适当增加
- 批准号:
8618912 - 财政年份:2013
- 资助金额:
$ 6.84万 - 项目类别:
Prenatal Bisphenol A Exposure and Risk of Gestational Diabetes
产前双酚 A 暴露与妊娠期糖尿病的风险
- 批准号:
9181415 - 财政年份:2012
- 资助金额:
$ 6.84万 - 项目类别:
Prenatal Bisphenol A Exposure and Risk of Gestational Diabetes
产前双酚 A 暴露与妊娠期糖尿病的风险
- 批准号:
8585062 - 财政年份:2012
- 资助金额:
$ 6.84万 - 项目类别:
Prenatal Bisphenol A Exposure and Risk of Gestational Diabetes
产前双酚 A 暴露与妊娠期糖尿病的风险
- 批准号:
8440084 - 财政年份:2012
- 资助金额:
$ 6.84万 - 项目类别:
Prenatal Bisphenol A Exposure and Risk of Gestational Diabetes
产前双酚 A 暴露与妊娠期糖尿病的风险
- 批准号:
8965507 - 财政年份:2012
- 资助金额:
$ 6.84万 - 项目类别:
HDS CDTR Diabetes and Obesity Prevention Core
HDS CDTR 糖尿病和肥胖预防核心
- 批准号:
9186357 - 财政年份:2011
- 资助金额:
$ 6.84万 - 项目类别:
Comparative effectiveness of diabetes prevention strategies in women with GDM
GDM 女性糖尿病预防策略的有效性比较
- 批准号:
8009287 - 财政年份:2010
- 资助金额:
$ 6.84万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 6.84万 - 项目类别:
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
- 批准号:
10681998 - 财政年份:2023
- 资助金额:
$ 6.84万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 6.84万 - 项目类别:
Toward Accurate Cardiovascular Disease Prediction in Hispanics/Latinos: Modeling Risk and Resilience Factors
实现西班牙裔/拉丁裔的准确心血管疾病预测:风险和弹性因素建模
- 批准号:
10852318 - 财政年份:2023
- 资助金额:
$ 6.84万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 6.84万 - 项目类别: